BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32403220)

  • 1. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
    Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
    PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
    Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
    J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 plasticity and its relevance to inflammatory bowel disease.
    Ueno A; Jeffery L; Kobayashi T; Hibi T; Ghosh S; Jijon H
    J Autoimmun; 2018 Feb; 87():38-49. PubMed ID: 29290521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
    Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
    Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 plasticity and its changes associated with inflammatory bowel disease.
    Ueno A; Ghosh A; Hung D; Li J; Jijon H
    World J Gastroenterol; 2015 Nov; 21(43):12283-95. PubMed ID: 26604637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
    Vyas SP; Goswami R
    Front Immunol; 2018; 9():1139. PubMed ID: 29881387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
    de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients.
    Bsat M; Chapuy L; Rubio M; Wassef R; Richard C; Schwenter F; Loungnarath R; Soucy G; Mehta H; Sarfati M
    Front Immunol; 2019; 10():1177. PubMed ID: 31191543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease: the classic gastrointestinal autoimmune disease.
    Kaistha A; Levine J
    Curr Probl Pediatr Adolesc Health Care; 2014 Dec; 44(11):328-34. PubMed ID: 25499459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.